Picture of Liminal BioSciences logo

LMNL — Liminal BioSciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular

Sept 12 (Reuters) - Liminal BioSciences Inc  LMNL.O :
    * LIMINAL BIOSCIENCES INC - FILES AMENDED SCHEDULE 13E-3 AND
SUPPLEMENT TO MANAGEMENT INFORMATION CIRCULAR
    * LIMINAL -AMENDMENT TO SCHEDULE 13E-3 WILL BE FILED TO
ADDRESS
COMMENTS RAISED BY SEC IN CONNECTION WITH PLAN OF ARRANGEMENT
WITH STRUCTURED ALPHA LP
    * LIMINAL BIOSCIENCES INC - NO CHANGES HAVE BEEN MADE TO
TERMS OR
CONDITIONS OF ARRANGEMENT
    * LIMINAL BIOSCIENCES INC - TO DATE, ABOUT 71% OF VOTES HAVE
BEEN
RECEIVED, OF WHICH A SUBSTANTIAL MAJORITY OF SUCH VOTES ARE IN
FAVOUR OF ARRANGEMENT
    * LIMINAL BIOSCIENCES INC - NO CHANGES HAVE BEEN MADE TO
DATE OF
SPECIAL MEETING OF COMPANY'S SHAREHOLDERS CALLED TO VOTE ON
ARRANGEMENT

Source text for Eikon:  ID:nCNWDRNL5a 
Further company coverage:  LMNL.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Liminal BioSciences

See all news